KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Capital Expenditures (2016 - 2025)

Xylem (XYL) has 16 years of Capital Expenditures data on record, last reported at $83.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 17.0% year-over-year to $83.0 million; the TTM value through Dec 2025 reached $336.0 million, up 4.67%, while the annual FY2025 figure was $331.0 million, 3.12% up from the prior year.
  • Capital Expenditures reached $83.0 million in Q4 2025 per XYL's latest filing, up from $79.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $100.0 million in Q4 2024 and bottomed at $39.0 million in Q1 2021.
  • Average Capital Expenditures over 5 years is $63.7 million, with a median of $60.0 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: skyrocketed 72.34% in 2021, then plummeted 43.24% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $81.0 million in 2021, then fell by 25.93% to $60.0 million in 2022, then surged by 56.67% to $94.0 million in 2023, then increased by 6.38% to $100.0 million in 2024, then dropped by 17.0% to $83.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $83.0 million in Q4 2025, $79.0 million in Q3 2025, and $42.0 million in Q1 2025.